This content is restricted.
Brief
"On 25/04/2025, the Korea Food and Drug Administration (KFDA) issued an update regarding Food and Drug Safety Evaluation Institute, Korea Biotechnology Research Institute signed a business agreement (MOU). The MOU aims to strengthen cooperation in research and regulation science for advanced biomedical products, including bio-drugs, pharmaceuticals, and toxicity evaluation. This collaboration is expected to lead to the development of innovative medical products and enhanced regulatory science."
Highlights content goes here...
This content is restricted.
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested